Electromed Inc. (ELMD), a global medical device company, said it has received notification from the U.S. Food and Drug Administration that its next generation SmartVest Airway Clearance System, the model SQL has been cleared to market.
"SQL solidifies Electromed's innovation leadership by offering a device that is smaller, quieter, and lighter than our previous versions," said Kathleen Skarvan, Chief Executive. He added, "We designed the SQL to stand apart from the competition with features that our patients and clinicians were asking for. They talked, and we listened."
The model SQL is an electrically powered precursor device designed to deliver high frequency chest wall oscillation to promote airway clearance, improve bronchial drainage and enhance mucus transport under the order of a physician's prescription.
The model SQL is expected to be available to the U.S. market within the next 60 days.
by RTT Staff Writer
For comments and feedback: firstname.lastname@example.org